PLGA, PLA, PCL polymers for Controlled Drug Delivery

Introduction: PLGA Inhalable Microparticle Development combines polymer science, particle engineering, analytical characterization, and inhalation-product performance testing to create a formulation […]

Introduction Selecting between Spray Drying vs Solvent Evaporation for poly(lactic-co-glycolic acid) (PLGA) microsphere fabrication requires careful consideration of processing throughput,

Introduction Poly(lactic-co-glycolic acid)-PEG Block Copolymers influence the biological fate of nanoparticles by creating a hydrophilic, sterically protective outer layer that

Introduction To accurately measure encapsulation efficiency in PLGA microspheres, analytical scientists employ either direct organic extraction techniques that dissolve the

Introduction Off-the-shelf poly(lactic-co-glycolic acid) (PLGA) polymers often fall short in advanced drug delivery applications because of broad polydispersity indices, batch-to-batch

Introduction: PLGA vs PLGA-PEG for nanoparticle drug delivery is one of the first formulation decisions a sponsor faces when designing

Introduction Poly(lactic-co-glycolic acid) characterization provides the essential analytical data required to control degradation rates, optimize drug entrapment, and ensure batch-to-batch

Introduction: PLA nanoparticle formulation for targeted oncology delivery is one of the more demanding areas of parenteral drug development, because

Introduction The primary biophysical distinction between PLGA 50:50 and PLGA 75:25 is defined by their monomer composition, specifically the ratio

Introduction Poly(lactic-co-glycolic acid) (PLGA)-based particulate delivery systems offer a highly biocompatible and biodegradable platform for protecting fragile biomolecules while enabling